Evidence map›Paper›PMID 21335486›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.

Taewoong Choi, Stephen T Ferris, Naoki Matsumoto, Jennifer Poursine-Laurent, Wayne M Yokoyama

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Functional Characterization of Ly49Frontiers in immunology · 2020
    Article
  6. Article
  7. Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Review
  9. Article
  10. Natural killer cell licensing in mice with inducible expression of MHC class I.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Taewoong ChoiRheumatology Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Stephen T Ferris
Naoki Matsumoto
Jennifer Poursine-Laurent
Wayne M Yokoyama
Washington University in St. Louis · USHoward Hughes Medical Institute · USThe University of Tokyo · JP

Funding

Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI WEIHL, CONRAD C · 2001 to 2015
$8.9M
INVIVO DEVELOPMENT OF NATURAL KILLER CELLSR01AI033903 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1992 to 2015
$4.0M
Activation Receptors on NK CellsR37AI034385 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2002 to 2011
$2.6M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI033903NIAID NIH HHS R37 AI034385NIAMS NIH HHS P30 AR048335
6 · The paper itself

Abstract

NK cells become functionally competent to be triggered by their activation receptors through the interaction of NK cell inhibitory receptors with their cognate self-MHC ligands, an MHC-dependent educational process termed "licensing." For example, Ly49A(+) NK cells become licensed by the interaction of the Ly49A inhibitory receptor with its MHC class I ligand, H2D(d), whereas Ly49C(+) NK cells are licensed by H2K(b). Structural studies indicate that the Ly49A inhibitory receptor may interact with two sites, termed site 1 and site 2, on its H2D(d) ligand. Site 2 encompasses the α1/α2/α3 domains of the H2D(d) H chain and β(2)-microglobulin (β2m) and is the functional binding site for Ly49A in effector inhibition. Ly49C functionally interacts with a similar site in H2K(b). However, it is currently unknown whether this same site is involved in Ly49A- or Ly49C-dependent licensing. In this study, we produced transgenic C57BL/6 mice expressing wild-type or site 2 mutant H2D(d) molecules and studied whether Ly49A(+) NK cells are licensed. We also investigated Ly49A- and Ly49C-dependent NK licensing in murine β2m-deficient mice that are transgenic for human β2m, which has species-specific amino acid substitutions in β2m. Our data from these transgenic mice indicate that site 2 on self-MHC is critical for Ly49A- and Ly49C-dependent NK cell licensing. Thus, NK cell licensing through Ly49 involves specific interactions with its MHC ligand that are similar to those involved in effector inhibition.

Indexed as

Cytotoxicity, ImmunologicAnimalsbeta 2-MicroglobulinCell CommunicationH-2 AntigensHistocompatibility Antigen H-2DKiller Cells, NaturalLigandsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicModels, AnimalNK Cell Lectin-Like Receptor Subfamily ANK Cell Lectin-Like Receptor Subfamily Cbeta 2-MicroglobulinH-2 AntigensH-2Kb protein, mouseHistocompatibility Antigen H-2DLigandsNK Cell Lectin-Like Receptor Subfamily ANK Cell Lectin-Like Receptor Subfamily C

Identifiers

PMID21335486
PMCPMC3082152
OpenAlexW1631454955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.